Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,712 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,712 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,712 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,712 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,712 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,712 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,712 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Dec 2025
Sam Eaton Chief Technology Officer
Sold on a plan
$5.63K 195 at 28.85
0.2%
Planned (10b5-1)
2 Dec 2025
Harry R. Trout III See Remarks
Sold at will
$5.30K 380 at 13.96
2.2%
Not planned
2 Dec 2025
Yolanda Macias Chief Motion Pictures Officer
Sold at will
$5.30K 2,189 at 2.42
2.3%
Not planned
2 Dec 2025
Alexis G. Alexander Vice President
Sold at will
$5.19K 127 at 40.87
3.8%
Not planned
2 Dec 2025
Nicholas Caezza Deputy General Counsel
Sold at will
$4.77K 1,686 at 2.83
0.7%
Not planned
2 Dec 2025
James Schladen President of Arcadia · indirect
Sold at will
$4.69K 782 at 6.00
0.1%
Not planned
2 Dec 2025
Bought
$4.38K 1,250 at 3.50
1.3%
2 Dec 2025
Ichiro Aoki President
Sold at will
$4.13K 1,166 at 3.54
1.4%
Not planned
2 Dec 2025
Paul L Alpern VP and General Counsel
Sold on a plan
$3.82K 258 at 14.82
0.4%
Planned (10b5-1)
2 Dec 2025
James M Roth Chief Revenue Officer
Sold on a plan
$3.47K 343 at 10.12
0.6%
Planned (10b5-1)
2 Dec 2025
Kathleen S. Capps See Remarks
Sold at will
$2.89K 207 at 13.96
2.3%
Not planned
2 Dec 2025
Donald Klimoski II General Counsel
Bought
$2.25K 446 at 5.05
0.5%
2 Dec 2025
Murray Stahl President/Co-Portfolio Manager · indirect
Bought 6×
$1.97K 774 at 2.55
0.2%
2 Dec 2025
Murray Stahl President/Co-Portfolio Manager
Bought
$918.00 360 at 2.55
0.3%
2 Dec 2025
Husnal Shah Chief Product Officer
Sold on a plan
$836.79 263 at 3.18
3.5%
Planned (10b5-1)
2 Dec 2025
Ashley McGrane General Counsel and Corp Sec
Sold on a plan
$728.64 72 at 10.12
0.3%
Planned (10b5-1)
2 Dec 2025
Scott T Bauer President of subsidiary bank
Bought
$433.56 20 at 21.68
0.5%
2 Dec 2025
Milton C Ault III Executive Chairman
Bought
$292.10 1,000 at 0.29
4.1%
1 Dec 2025
Patrick Dumont President & COO
Sold at will
$14.71M 210,305 at 69.96
32.0%
Not planned
1 Dec 2025
Gary S Guthart Executive Chair of the Board o
Sold on a plan
$13.02M 22,806 at 570.89
89.4%
Sold half or more
1 Dec 2025
Michael Benkowitz President and COO · indirect
Sold on a plan 14×
$10.80M 22,500 at 479.91
100%
Sold half or more
1 Dec 2025
Nikhil Chandhok Chief Product & Tech. Officer
Sold at will 4×
$7.71M 100,000 at 77.08
16.8%
Not planned
1 Dec 2025
Terilyn J. Monroe Chief People Officer
Sold on a plan 7×
$5.85M 55,167 at 105.97
72.5%
Sold half or more
1 Dec 2025
Sylebra Capital LLC See Footnote · indirect
Sold at will
$5.19M 31,058 at 167.02
1.9%
Not planned
1 Dec 2025
Brian M Venturo Chief Strategy Officer · indirect
Sold on a plan 16×
$4.92M 65,606 at 74.95
26.4%
Planned (10b5-1)
1 Dec 2025
Bertrand Loy Executive Chair
Sold on a plan 3×
$4.43M 57,570 at 76.88
15.8%
Planned (10b5-1)
1 Dec 2025
Mark T Mondello Executive Chairman
Sold on a plan 6×
$4.24M 20,000 at 212.20
1.6%
Planned (10b5-1)
1 Dec 2025
Frederick M. Lowery Executive Vice President
Sold on a plan
$4.13M 6,913 at 597.68
32.5%
Planned (10b5-1)
1 Dec 2025
Benjamin E. Huston Chief Operating Officer
Sold on a plan 11×
$3.77M 10,000 at 377.11
9.0%
Planned (10b5-1)
1 Dec 2025
D. Zachary Hudson EVP and Global General Counsel
Sold at will
$3.75M 53,257 at 70.37
79.5%
Sold half or more
1 Dec 2025
Brian Mandell Executive Vice President
Sold at will
$3.57M 25,500 at 140.04
31.0%
Not planned
1 Dec 2025
Yann L Etienvre Chief Operations Officer
Sold at will
$2.97M 9,187 at 323.38
100%
Sold half or more
1 Dec 2025
Raymond A Ritchey Senior EVP
Sold at will
$2.62M 36,314 at 72.18
100%
Sold half or more
1 Dec 2025
Christian Kleinerman EVP, Product Management
Sold on a plan
$2.50M 10,000 at 249.53
1.9%
Planned (10b5-1)
1 Dec 2025
Yoav Landman Chief Technology Officer
Sold on a plan
$2.40M 40,000 at 60.08
0.7%
Planned (10b5-1)
1 Dec 2025
Curtis E Garner Pres, Chief Strgy & Tech Off
Sold at will
$2.15M 61,892 at 34.67
17.2%
Not planned
1 Dec 2025
Manuel JM Steijaert EVP - President, IOM
Sold on a plan
$2.01M 6,567 at 305.50
58.8%
Sold half or more
1 Dec 2025
Martina M.D. Flammer Chief Medical Officer
Sold on a plan 3×
$1.84M 8,895 at 206.98
9.7%
Planned (10b5-1)
1 Dec 2025
R Stanton Dodge Chief Legal Officer
Sold on a plan 2×
$1.79M 52,777 at 33.84
9.3%
Planned (10b5-1)
1 Dec 2025
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC
Sold on a plan
$1.76M 17,313 at 101.55
42.3%
Planned (10b5-1)
1 Dec 2025
Sean Maduck See Remarks
Sold on a plan
$1.59M 20,000 at 79.52
71.7%
Sold half or more
1 Dec 2025
Vivek Jain EVP, Global Operations
Sold at will
$1.57M 5,914 at 265.84
13.2%
Not planned
1 Dec 2025
Thomas G Cromwell EVP and COO
Sold on a plan
$1.50M 5,000 at 299.39
24.8%
Planned (10b5-1)
1 Dec 2025
Chad Roberts EVP, Production Solutions
Sold on a plan
$1.31M 77,389 at 16.94
23.3%
Planned (10b5-1)
1 Dec 2025
Dongfang Liu Chief Medical Officer
Sold at will
$1.17M 150,000 at 7.82
89.3%
Sold half or more
1 Dec 2025
Sukumar Nagendran President and Head of R&D
Sold at will
$1.17M 260,047 at 4.51
20.5%
Not planned
1 Dec 2025
Samsheer Ahamad See Remarks
Sold on a plan
$1.16M 4,000 at 291.10
7.2%
Planned (10b5-1)
1 Dec 2025
Bar Veinstein President, A&G
Sold on a plan
$1.16M 309,902 at 3.74
26.7%
Planned (10b5-1)
1 Dec 2025
Leila Wong Chief Human Resources Officer
Sold at will
$1.02M 3,160 at 323.38
18.5%
Not planned
1 Dec 2025
Sold on a plan
$948.12K 4,827 at 196.42
4.2%
Planned (10b5-1)
Showing 20,801–20,850 of 22,712. ← Newer Page 417 of 455 Older →